Anti-VISTA Monoclonal Antibody HMBD-002

Preferred Label : Anti-VISTA Monoclonal Antibody HMBD-002;

NCIt definition : An immunoglobulin G4 (IgG4) monoclonal antibody directed against the negative immune checkpoint regulatory protein V-domain Ig suppressor of T-cell activation (VISTA; programmed death 1 homolog; PD1H; PD-1H), with potential negative immune checkpoint regulatory and antineoplastic activities. Upon administration, anti-VISTA monoclonal antibody HMBD-002 targets and binds to VISTA on monocytes and T-cells. This inhibits VISTA-mediated signaling, decreases the presence of monocytic myeloid-derived suppressor cells (MDSCs), increases the presence of activated dendritic cells (DCs) and abrogates VISTA-induced suppression of T-lymphocyte immune responses. This enhances cytotoxic T-cell infiltration, proliferation and activation within the tumor microenvironment (TME), increases cytokine production by T-cells, and inhibits tumor cell growth. VISTA, a negative checkpoint molecule of immune activation, is highly expressed on myeloid cells, T-cells and in several tumor types. It plays a key role in the suppression of T-cell function.;

Molecule name : HMBD-002; HMBD 002;

NCI Metathesaurus CUI : CL1773471;

Details

Origin ID

C185122;

UMLS CUI

C5666939;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- V-Type Immunoglobulin Domain-Containing Suppressor of T-Cell Activation [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients